Aurobindo Pharmaceuticals

🔎 Run a search for “Aurobindo Pharmaceuticals”

Get RSS feed of these results

All stories

Story
13 February 2017

India: 2017 Responsible Business Index ranks top 100 listed companies

In an attempt to gauge how Indian firms are coping with the interests of various stakeholders, a collaborative effort of non-profits—Oxfam India, Corporate Responsibility Watch, Praxis and Partners in Change—has put together the second edition of...

See full story

Article
17 July 2015

India: Tergene Biotech develops affordable pneumonia vaccine

Author: M Somasekhar, Hindu (India)

"Tergene Biotech develops vaccine to combat pneumonia", 16 Jul 2015...

Read more

Story
9 October 2008

Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions

See full story

Article
9 October 2008

Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS

Author: United Nations

I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...

Read more

Article
29 April 2008

Deal lowers price of second-line therapy and makes new paediatric formulations available to poorer countries

Author: Michael Carter, Aidsmap

Further reductions in the prices of generic versions of key second-line antiretroviral drugs were announced yesterday, thanks to an agreement negotiated by the international drug purchase fund UNITAID and the Clinton HIV/AIDS Initiative with Indian...

Read more

Article
10 August 2007

Cipla quarrels with AIDS activists on price of drug

Author: Marc Iskowitz, Medical Marketing & Media

The AIDS Healthcare Foundation...mounted a new advocacy campaign yesterday challenging Cipla for an alleged price disparity between what the firm charges for its generic drugs in India vs. Africa. Cipla refuted the over-pricing charges in ads of its...

Read more

Article
31 May 2007

Boehringer offers HIV drug without patents

Author: Bhuma Shrivastava, Mint [India]

...Boehringer Ingelheim has decided not to enforce patents on its anti-HIV drug, Nevirapine, in 78 low-income African and Asian countries...In a statement on its website, Boehringer says it will issue “short, non-assert declarations”, or licences, to...

Read more

Story
30 November 2006

Cipla, Ranbaxy to cut paediatric antiretroviral drug prices to as low as $60/year for poor countries ahead of World AIDS Day under deal with Clinton Foundation

See full story

Article
30 November 2006

President Clinton Announces Breakthroughs in HIV/AIDS Treatment for Children— 3-in-1 Pill for less than $60 Annually and 45% Price Reductions for other Pediatric Drugs

Author: Clinton Foundation [USA]

President Bill Clinton announced today that his foundation has negotiated new agreements to lower the price of HIV/AIDS treatment for children. Cipla and Ranbaxy will price a new child-friendly product...for less than $60 per year... The new prices...

Read more

Article
25 September 2006

Indian Firms to Make HIV Drug - Gilead Sciences licenses AIDS treatment Tenofovir to eight more Indian companies

Author: Red Herring [USA]

Eight more Indian companies have received nonexclusive licenses from Gilead Sciences to manufacture and distribute the HIV drug Tenofovir...The [eight] Indian drug companies that struck the licensing deal were [Ranbaxy Laboratories], Aurobindo Pharma,...

Read more